Literature DB >> 1700468

Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells.

S Panzer1, R L Geller, F H Bach.   

Abstract

Accessory cells (AC) are believed to play two major roles in T-cell activation: they cross-link certain stimuli such as monoclonal antibodies, and they provide needed cytokines. To differentiate between these roles, we cross-linked OKT3 on highly purified T cells by means of Fc-specific goat anti-mouse IgG-coated polystyrene beads and studied T-cell activation after exogenously added cytokines. Following addition of AC, rIL-2, or rIL-1, CD25 was up-regulated, and the cells proliferated and became cytotoxic. Both CD4+ and CD8+ cells were activated in the presence of AC or rIL-2. In contrast, only CD4+CD29+CD45RA- cells responded in the presence of rIL-1. Anti-IL-2R p55 (anti-TAC) monoclonal antibody inhibited the proliferative response supported by rIL-2 or rIL-1. To inhibit proliferation of cells stimulated in the presence of AC, anti-TAC needed to be supplemented with anti-IL-6 antibodies, or to be added in a 10-fold higher concentration. Cultures with AC produced larger amounts of IL-2 than those supplemented with rIL-1. Only AC-containing cultures also produced detectable amounts of IL-6. These findings combined with the observation that none of 2000 purified T cells counted in each of six independent experiments expressed MHC class II antigens strongly suggest that rIL-1 can activate T cells directly, rather than indirectly by potentiating the function of contaminating AC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700468     DOI: 10.1111/j.1365-3083.1990.tb02930.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  A multigene family on human chromosome 12 encodes natural killer-cell lectins.

Authors:  T Yabe; C McSherry; F H Bach; P Fisch; R P Schall; P M Sondel; J P Houchins
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

2.  Interaction of IL-1 beta, IL-6 and tumour necrosis factor-alpha (TNF-alpha) in human T cells activated by murine antigens.

Authors:  S Panzer; M Madden; K Matsuki
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

3.  Adoptive tumour immunotherapy using human CD4+ T-cells.

Authors:  J E Gold; M E Osband
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

4.  IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells.

Authors:  Shlomo Z Ben-Sasson; Alison Hogg; Jane Hu-Li; Paul Wingfield; Xi Chen; Michelle Crank; Stephane Caucheteux; Maya Ratner-Hurevich; Jay A Berzofsky; Ran Nir-Paz; William E Paul
Journal:  J Exp Med       Date:  2013-03-04       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.